Back to LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA

REGNREGN
23 quarters

Position history for LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MALORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA's holdings in REGENERON PHARMACEUTICALS

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds 65,875 shares of REGN (REGENERON PHARMACEUTICALS), worth $41.1M as of 2026-Q2. The position was decreased (-9.1% shares). REGN represents 0.4% of LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA's portfolio.

Current Value

$41.1M

Current Shares

65,875

Total Value Change

+$41M

Total Shares Change

+65,715

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
65,875
-9.1%
$41.1M0.4%$622.81
0
2026-Q1
Decreased
72,430
-16.7%
$54.2M0.5%$770.59
0
2025-Q4
Decreased
86,975
-5.2%
$67.1M0.6%$768.90
0
2025-Q3
Decreased
91,727
-8.2%
$52.8M0.5%$559.40
0
2025-Q2
Increased
99,913
+3.6%
$52.5M0.5%$521.53
36
2025-Q1
Decreased
96,473
-9.1%
$56.7M0.6%$629.11
0
2024-Q4
Decreased
106,091
-3.1%
$72.6M0.6%$705.67
0
2024-Q3
Increased
109,481
+5.6%
$101.7M0.9%$1,041.41
45
2024-Q2
Increased
103,680
+18.8%
$113.5M1.0%$1,041.20
56
2024-Q1
Increased
87,274
+42.0%
$78.6M0.8%$953.49
56
2023-Q4
Increased
61,446
+39.9%
$57.9M0.6%$870.08
55
2023-Q3
Increased
43,917
+162.4%
$36M0.4%$815.27
56
2023-Q2
Increased
16,736
+31.6%
$12M0.1%$711.82
42
2023-Q1
Increased
12,720
+1.0%
$10.5M0.1%$813.99
33
2022-Q4
Increased
12,597
+5.6%
$9.1M0.1%$714.75
35
2022-Q3
Increased
11,934
+8.4%
$8.2M0.1%$682.43
36
2022-Q2
Increased
11,005
+0.8%
$6.5M0.1%$585.60
27
2022-Q1
Increased
10,913
+0.7%
$7.6M0.1%$691.89
27
2021-Q4
Increased
10,842
+1.3%
$6.8M0.1%$625.62
28
2021-Q3
Increased
10,707
+0.2%
$6.5M0.1%$599.52
27
2021-Q2
Increased
10,685
+5.4%
$6M0.1%$553.32
29
2021-Q1
Increased
10,135
+6234.4%
$4.8M0.1%$468.72
43
2020-Q4
New
160
-
$77,0000.0%$478.59
29

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used